The EU General Court confirms the decision of the Commission concerning its first pharma pay-for-delay case (Lundbeck)

General Court’s pay for delay judgment in Lundbeck – some guidance, but worries remain* On 8 September, the General Court handed down its eagerly awaited decision in Lundbeck – the first ever European judgment concerning so-called pay for delay settlements. The Commission’s decision in this case was heavily criticised by practitioners as well as academics like myself for taking the view that agreements in question would constitute a ‘restriction by object’. In a previous blog I argued that the Commission might have pushed it too far by finding this kind of agreement an object restriction, especially in the light of the Court of Justice’s decision in Groupement des Cartes Bancaires, where it was held that such restrictions should be interpreted ‘restrictively’. It is therefore perhaps

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • University of East Anglia

Quotation

Sven Gallasch, The EU General Court confirms the decision of the Commission concerning its first pharma pay-for-delay case (Lundbeck), 8 September 2016, e-Competitions Bulletin Competition in the Pharmaceutical sector, Art. N° 81335

Visites 71

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues